Our Pricing

Is Ozempic Wegovy? Understanding the Differences and UK Costs

Published on: June 03, 2026

Many UK patients ask is Ozempic Wegovy when researching semaglutide-based weight loss treatments. While both medications contain the same active ingredient—semaglutide—they are licensed for different purposes, use different dosing schedules, and carry different price points in the UK. At Cured Pharmacy, we help clarify these distinctions so you can make an informed choice with transparent pricing from £79.00.

Is Ozempic the Same as Wegovy?

No, Ozempic and Wegovy are not the same medication, though they share the same active pharmaceutical ingredient: semaglutide. Ozempic is licensed by the MHRA exclusively for managing type 2 diabetes, whilst Wegovy is licensed specifically for chronic weight management in adults with obesity or overweight conditions [1].

The critical difference lies in dosing and clinical indication. Ozempic is typically prescribed at maintenance doses of 0.5mg or 1mg weekly for glycaemic control, whereas Wegovy escalates to a maximum maintenance dose of 2.4mg weekly—optimised for sustained appetite suppression and weight reduction [1][2]. Prescribing Ozempic off-label for weight loss is not recommended by UK clinical guidelines, as Wegovy has undergone specific trials for obesity treatment.

Both medications work as GLP-1 receptor agonists, mimicking the natural hormone glucagon-like peptide-1 to slow gastric emptying, reduce appetite, and improve insulin sensitivity. However, Wegovy's higher therapeutic dose has been shown in the STEP clinical programme to deliver average body weight reductions of 14.9% over 68 weeks, compared to 2.4% with placebo [2].

Wegovy UK Monthly Cost Breakdown

At Cured Pharmacy, Wegovy is available from £79.00 per month, making it one of the most competitively priced semaglutide weight loss treatments in the UK. This transparent upfront pricing includes your medication, free online consultation with a UK-registered prescriber, and discreet home delivery.

Monthly costs vary depending on your prescribed dose tier. Treatment begins with a gradual dose escalation over 16-20 weeks to minimise gastrointestinal side effects, starting at 0.25mg weekly and building to the 2.4mg maintenance dose. Your UK prescriber will tailor the titration schedule based on your tolerability and clinical response during ongoing assessments.

Unlike some online pharmacies that advertise lower entry prices but add hidden consultation fees or delivery charges, Cured Pharmacy guarantees transparent pricing with no unexpected costs. All prescription medications require clinical approval by a UK prescriber, and your final monthly cost will be confirmed before you proceed with treatment.

What's Included in the Price

Every Wegovy prescription from Cured Pharmacy includes a comprehensive service: free online clinical consultation completed in under three minutes, review by our UK-registered clinical team led by Superintendent Pharmacist Tarun Kumar (GPhC 2233073), genuine UK-licensed medication dispensed from our GPhC-registered pharmacy (9012511), and 100% discreet packaging delivered directly to your door. There are no hidden fees, no subscription traps, and no pressure to continue beyond your chosen treatment duration.

Ozempic vs Wegovy for Weight Loss: Which Should You Choose?

If your primary goal is weight management, Wegovy is the clinically appropriate choice. It has been specifically trialled and licensed for obesity treatment in the UK, with robust evidence from the STEP trial programme demonstrating significant and sustained weight loss when combined with lifestyle interventions [2].

Ozempic, whilst effective for blood sugar control in type 2 diabetes, is not licensed for weight loss. Prescribing it off-label for obesity may result in suboptimal dosing and lack of clinical monitoring tailored to weight management outcomes. UK prescribers are guided by MHRA licensing and NICE recommendations, which support Wegovy as the evidence-based semaglutide option for weight loss [3].

That said, some patients with both type 2 diabetes and obesity may be prescribed Ozempic for glycaemic control, with weight loss as a secondary benefit. Your UK prescriber will assess your full medical history, current medications, BMI, and treatment goals to determine the most suitable option during your consultation.

Clinical Trial Evidence

The STEP 1 trial enrolled 1,961 adults with obesity or overweight and demonstrated that participants receiving Wegovy 2.4mg weekly achieved an average 14.9% reduction in body weight over 68 weeks, compared to 2.4% in the placebo group [2]. Additionally, 86.4% of Wegovy-treated participants lost at least 5% of their baseline weight—a threshold associated with meaningful metabolic improvements—compared to 31.5% in the placebo arm. These results underscore Wegovy's efficacy when used as part of a comprehensive weight management programme including dietary modification and increased physical activity.

Alternative Weight Loss Treatments Available at Cured Pharmacy

Beyond Wegovy, Cured Pharmacy offers a range of MHRA-licensed weight loss treatments to suit different clinical profiles and budgets. Mounjaro (tirzepatide) is a dual GIP/GLP-1 receptor agonist that has shown superior weight loss outcomes in head-to-head trials, with participants in the SURPASS-2 study achieving up to 22.5% body weight reduction over 72 weeks [4].

For patients seeking daily injection options, Saxenda (liraglutide) provides an alternative GLP-1 therapy with a well-established safety profile. Oral treatments such as Orlistat and Mysimba offer non-injectable alternatives for those who prefer tablet-based regimens. Each medication requires individual clinical assessment to ensure suitability, tolerability, and alignment with your weight management goals.

Your UK prescriber will consider factors including your BMI, existing health conditions, previous weight loss attempts, and personal preferences when recommending a treatment pathway. All consultations are conducted by qualified UK healthcare professionals, and you retain full control over whether to proceed with any recommended prescription.

How to Start Your Weight Loss Treatment at Cured Pharmacy

Starting your weight loss journey with Cured Pharmacy is straightforward and discreet. Begin by completing our free online consultation, which takes under three minutes and covers your medical history, current medications, weight loss goals, and any contraindications. Your responses are reviewed by a UK-registered prescriber who will assess your suitability for treatment.

If approved, your prescription is sent electronically to our GPhC-registered pharmacy, where your medication is dispensed and dispatched in 100% discreet packaging. Delivery is prompt, reliable, and tracked, ensuring your treatment arrives safely at your chosen address. If the prescriber determines that weight loss medication is not clinically appropriate for you at this time, they will provide guidance on alternative approaches or recommend follow-up with your GP.

Ongoing support is available throughout your treatment. You can contact our clinical team with any questions about side effects, dosing, or treatment adjustments. Regular follow-up consultations ensure your treatment remains safe, effective, and aligned with your evolving health needs.

Why Choose Cured Pharmacy for Weight Loss Treatment

Cured Pharmacy combines competitive pricing with clinical excellence and patient-centred care. Our transparent upfront pricing means you see the cost before completing your consultation—no surprises, no hidden fees. We guarantee genuine UK-licensed medications dispensed under the supervision of Superintendent Pharmacist Tarun Kumar (GPhC 2233073), ensuring every prescription meets the highest regulatory standards. With a UK-registered clinical team, discreet delivery, and a commitment to the lowest prices in the UK, we make evidence-based weight loss treatment accessible, affordable, and trustworthy.

Understanding Semaglutide Side Effects and Safety

Both Ozempic and Wegovy share a similar side effect profile, as they contain the same active ingredient. The most commonly reported adverse effects are gastrointestinal, including nausea, vomiting, diarrhoea, and constipation, particularly during the initial dose escalation phase [1][2]. These symptoms typically diminish over time as your body adjusts to the medication.

Serious but rare side effects include pancreatitis, gallbladder disease, and hypoglycaemia (especially if used alongside other glucose-lowering medications). Semaglutide is contraindicated in patients with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 [1]. Your UK prescriber will screen for these conditions during your consultation.

To minimise side effects, treatment follows a gradual dose titration schedule, and patients are advised to maintain adequate hydration, eat smaller meals, and avoid high-fat foods. If you experience persistent or severe symptoms, contact your prescriber immediately for clinical review. Regular monitoring ensures any adverse effects are identified early and managed appropriately, maintaining both safety and treatment efficacy throughout your weight loss journey.

Who Should Not Use Semaglutide

Semaglutide-based treatments are not suitable for everyone. Contraindications include pregnancy or breastfeeding, a history of severe gastrointestinal disease (such as inflammatory bowel disease or gastroparesis), type 1 diabetes, diabetic ketoacidosis, or a personal or family history of medullary thyroid carcinoma. Patients with severe renal impairment or a history of pancreatitis should be assessed carefully, as semaglutide may not be appropriate. Your UK prescriber will review your full medical history to determine whether Wegovy or an alternative weight loss treatment is the safest and most effective option for you.

Scientific References

1. Novo Nordisk. (2023). Ozempic (semaglutide) Summary of Product Characteristics. Electronic Medicines Compendium. https://www.medicines.org.uk/emc/product/9758 [accessed 13 August 2026]
2. Wilding, J. P. H., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
3. National Institute for Health and Care Excellence. (2023). Semaglutide for managing overweight and obesity [TA875]. NICE. https://www.nice.org.uk/guidance/ta875 [accessed 13 August 2026]
4. Jastreboff, A. M., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
5. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
6. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
7. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.